The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine for humans.
The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million award for an mRNA-based H5N1 avian influenza vaccine that HHS granted Moderna in July 2024.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
